← Leaderboards
Arshed A Quyyumi
Heart, Lung, And Blood Institute
$19,415,873
Attributed
$22,810,190
Total exposure
27
Grants
26
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,695,244 · 29
By mechanism
P01$20,555,495 · 5
RF1$6,030,221 · 1
U01$3,050,176 · 1
R33$2,994,857 · 1
RC2$2,373,533 · 1
U54$1,618,170 · 1
Top collaborators
- Kabayam M Venkat Narayan4 shared
- Ihab M Hajjar3 shared
- Ighovwerha Ofotokun1 shared
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsFollow-UpFundingCardiovascular DiseasesEventAtherosclerosisRisk FactorsInflammationMyocardial InfarctionResourcesCardiovascular SystemBaseResearch PersonnelHigh RiskLeadInstitutionCohortDisease ProgressionFunctional DisorderPathway InteractionsMediatingCoronaryVascular DiseasesEndothelium
Grant awards (76)
Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)$2,304,661
P01 · FY2025 · HL
Prevalence, Incidence, and Predictors of Subclinical and Clinical Vascular and Myocardial Disease: Pathophysiologic Pathways$95,128
P01 · FY2025 · HL · contact PI
Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)$2,211,138
P01 · FY2024 · HL
Prevalence, Incidence, and Predictors of Subclinical and Clinical Vascular and Myocardial Disease: Pathophysiologic Pathways$128,135
P01 · FY2024 · HL · contact PI
Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)$2,289,655
P01 · FY2023 · HL
Prevalence, Incidence, and Predictors of Subclinical and Clinical Vascular and Myocardial Disease: Pathophysiologic Pathways$113,721
P01 · FY2023 · HL · contact PI
Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)$2,301,664
P01 · FY2022 · HL
Cardiovascular Disease (CVD) Phenotyping Core$411,285
P01 · FY2022 · HL · contact PI
Cardiovascular Project 3$323,634
U54 · FY2022 · AG · contact PI
Prevalence, Incidence, and Predictors of Subclinical and Clinical Vascular and Myocardial Disease: Pathophysiologic Pathways$113,721
P01 · FY2022 · HL · contact PI
Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial Disease$740,646
R33 · FY2021 · HL · contact PI
Cardiovascular Project 3$323,634
U54 · FY2021 · AG · contact PI
Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial Disease$743,039
R33 · FY2020 · HL · contact PI
Cardiovascular Project 3$323,634
U54 · FY2020 · AG · contact PI
Core to Support Underserved or Health Disparity Populations$107,488
P30 · FY2020 · DK · contact PI
Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial Disease$751,714
R33 · FY2019 · HL · contact PI
Cardiovascular Project 3$323,634
U54 · FY2019 · AG · contact PI
Core to Support Underserved or Health Disparity Populations$109,048
P30 · FY2019 · DK · contact PI
Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial Disease$759,458
R33 · FY2018 · HL · contact PI
Cardiovascular Project 3$323,634
U54 · FY2018 · AG · contact PI
Core to Support Underserved or Health Disparity Populations$134,008
P30 · FY2018 · DK · contact PI
Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial Disease$775,100
R61 · FY2017 · HL · contact PI
The role of the renin-angiotensin-endothelial pathway in AD$298,038
RF1 · FY2017 · AG
Core to Support Underserved or Health Disparity Populations$112,168
P30 · FY2017 · DK · contact PI
Community based assessments regarding vascular contributions to Alzheimers Disease in M2OVE AD consortium$497,270
RF1 · FY2016 · AG
Core to Support Underserved or Health Disparity Populations$126,740
P30 · FY2016 · DK · contact PI
The role of the renin-angiotensin-endothelial pathway in AD$5,234,913
RF1 · FY2015 · AG
Mental Stress Ischemia: Prognosis and Genetic Influences$2,125,629
P01 · FY2015 · HL · contact PI
Vascular Responses During Mental Stress$591,775
P01 · FY2015 · HL · contact PI
Mental Stress Ischemia: Prognosis and Genetic Influences$2,195,760
P01 · FY2014 · HL · contact PI
Injury and Repair Factors Promoting Atherosclerosis in HIV$758,413
R56 · FY2014 · HL · contact PI
Vascular Responses During Mental Stress$549,603
P01 · FY2014 · HL · contact PI
Mental Stress Ischemia: Prognosis and Genetic Influences$2,213,556
P01 · FY2013 · HL · contact PI
Vascular Responses During Mental Stress$300,611
P01 · FY2013 · HL · contact PI
Mental Stress Ischemia: Prognosis and Genetic Influences$20,844
P01 · FY2012 · HL · contact PI
Mental Stress Ischemia: Prognosis and Genetic Influences$2,222,147
P01 · FY2011 · HL · contact PI
Vascular Responses During Mental Stress$154,672
P01 · FY2011 · HL · contact PI
Phase II study: Mobilization of progenitor cells in peripheral arterial disease$1,193,039
RC2 · FY2010 · HL · contact PI
Vascular Responses During Mental Stress$211,790
P01 · FY2010 · HL · contact PI
Phase II study: Mobilization of progenitor cells in peripheral arterial disease$1,180,494
RC2 · FY2009 · HL · contact PI
The Emory-Morehouse Partnership to Reduce CV Disparities$557,530
U01 · FY2008 · HL · contact PI
Endothelial Hyperpolarization in Humans$362,679
R01 · FY2008 · HL · contact PI
The Emory-Morehouse Partnership to Reduce CV Disparities$636,714
U01 · FY2007 · HL · contact PI
Endothelial Hyperpolarization in Humans$362,679
R01 · FY2007 · HL · contact PI
EFFECT OF VALSARTAN ON CAROTID ATHEROSCLEROSIS, ENDOTHELIAL, OXIDATIVE STRESS,$35,862
M01 · FY2007 · RR · contact PI
ROLE OF ENDOTHELIUM-DERIVED HYPOLARIZING FACTOR$15,312
M01 · FY2007 · RR · contact PI
PREDICTIVE MEDICINE RESEARCH: INVESTIGATION OF HEALTH, SUB-CLINICAL ORGAN SYS$9,402
M01 · FY2007 · RR · contact PI
EMORY MOREHOUSE PARTNERSHIP TO REDUCE CARDIOVASCULAR HEALTH$8,731
M01 · FY2007 · RR · contact PI
EFFECT OF STATINS ON OXIDATIVE STRESS AND ENDOTHELIAL PROGENITOR CELLS:$6,447
M01 · FY2007 · RR · contact PI
EFFECT OF MEDITERRANEAN DIET ON OXIDATIVE STRESS AND ENDOTHELIAL PROGENITOR C$4,834
M01 · FY2007 · RR · contact PI
AMORCYTE MYOCARDIAL REPAIR STUDY - PHASE I$2,955
M01 · FY2007 · RR · contact PI
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLE$404
M01 · FY2007 · RR · contact PI
STUDY OF ALDOSTERONE BLOCKADE (EPLERENONE) IN WOMEN$268
M01 · FY2007 · RR · contact PI
The Emory-Morehouse Partnership to Reduce CV Disparities$585,898
U01 · FY2006 · HL · contact PI
Endothelial Hyperpolarization in Humans$373,511
R01 · FY2006 · HL · contact PI
COLONY STIMULATING FACTORS IN PATIENTS WITH INTERMITTENT CLAUDICATION$74,870
M01 · FY2006 · RR · contact PI
The Emory-Morehouse Partnership to Reduce CV Disparities$70,034
U01 · FY2006 · HL · contact PI
VALSARTAN$33,221
M01 · FY2006 · RR · contact PI
EFFECT OF MEDITERRANEAN DIET ON OBESITY$31,733
M01 · FY2006 · RR · contact PI
EFFECTS OF TETRAHYDROBIOPTERIN ON BLOOD PRESSURE$20,329
M01 · FY2006 · RR · contact PI
OXIDATIVE STRESS AND ENDOTHELIAL PROGENITOR CELLS$17,850
M01 · FY2006 · RR · contact PI
ROLE OF ENDOTHELIUM-DERIVED HYPOPOLARIZING FACTOR$2,975
M01 · FY2006 · RR · contact PI
The Emory-Morehouse Partnership to Reduce CV Disparities$600,000
U01 · FY2005 · HL
Endothelial Hyperpolarization in Humans$382,500
R01 · FY2005 · HL
COLONY STIMULATING FACTORS IN INTERMITTENT CLAUDICATION$136,827
M01 · FY2005 · RR
ROLE OF ENDOTHELIUM-DERIVED HYPOPOLARIZING FACTOR$2,105
M01 · FY2005 · RR
EFFECTS OF TETRAHYDROBIOPTERIN ON BLOOD PRESSURE$789
M01 · FY2005 · RR
The Emory-Morehouse Partnership to Reduce CV Disparities$600,000
U01 · FY2004 · HL
Role of Endothelium-Derived Hyperpolarizing Factor$61,402
M01 · FY2004 · RR
Granulocyte-Macrophage Colony Stimulating Factors$2,142
M01 · FY2004 · RR
Infection is a determinant of endothelial dysfunction &coronary flow reserve$0
Z01 · FY2000 · HL
Hemoxygenase and hyperpolarizing factor in control of peripheral vascular tone$0
Z01 · FY2000 · HL
Role of endothelin in human coronary vascular function$0
Z01 · FY2000 · HL
Electromechanical endocardial mapping for assessment of myocardial viabiiity$0
Z01 · FY2000 · HL
Investigations of the genetic basis for vascular dysfunction$0
Z01 · FY2000 · HL
CLINICAL VASCULAR BIOLOGY IN ATHEROSCLEROSIS$0
Z01 · FY2000 · HL